Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2007
04/11/2007CN1944433A 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine
04/11/2007CN1944432A 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine
04/10/2007US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
04/10/2007US7202266 PPAR active compounds
04/10/2007US7202255 Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007US7202245 Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines
04/10/2007US7202243 Substituted imidazotriazines
04/10/2007US7202240 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines
04/10/2007US7202239 Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
04/10/2007US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity
04/10/2007US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
04/10/2007CA2364199C Novel bicyclic derivatives of aminopyrazinone, process for their preparation and pharmaceutical compositions containing them
04/10/2007CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof
04/05/2007WO2007038648A1 Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
04/05/2007WO2007038630A2 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof
04/05/2007WO2007038314A2 Fused heterocyclic compounds useful as kinase modulators
04/05/2007WO2007038284A1 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE
04/05/2007WO2007038215A1 Tetracyclic inhibitors of janus kinases
04/05/2007WO2007038074A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands
04/05/2007WO2007037743A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia
04/05/2007WO2007037518A1 Mutilin derivative and pharmaceutical composition containing the same
04/05/2007WO2007037039A1 Method of producing a metal phthalocyanine compound, and method of producing a phthalocyanine compound and an analogue thereof
04/05/2007WO2007021575A3 Acetylenic piperazines as metabotropic glutamate receptor antagonists
04/05/2007US20070078149 6-(2-Halophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
04/05/2007US20070078138 Analogs of dehydrophenylahistins and their therapeutic use
04/05/2007US20070078136 Fused heterocyclic compounds useful as kinase modulators
04/05/2007US20070078132 tyrosine kinase inhibitors such as 7H,19H-4,6-ethanediylidenepyrimido[4,5-b][13,1,4,6]benzoxatriazacyclopentadecine, 17-chloro-8,9,10,11,12,13-hexahydro, used for treating hyper proliferative disorders such as atherosclerosis, restenosis and cancer
04/05/2007US20070078122 Indolobenzazepine HCV NS5B inhibitors
04/05/2007US20070077195 "N and/or nalpha derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3 (co)3]+ by fac coordination"
04/05/2007CA2624491A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia
04/05/2007CA2623369A1 Fused heterocyclic compounds useful as kinase modulators
04/05/2007CA2623252A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands
04/05/2007CA2623047A1 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5 amine
04/05/2007CA2623034A1 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
04/05/2007CA2622701A1 Amino-aza-adamantane derivatives and methods of use
04/05/2007CA2621261A1 Azepine inhibitors of janus kinases
04/04/2007EP1768985A1 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
04/04/2007EP1768983A2 Fused heterocyclic kinase inhibitors
04/04/2007EP1768982A2 Pyrolo [2,3-d] pyrimidines that modulate ack1 and lck activity
04/04/2007EP1576015A4 Preparation of metallotexaphyrins
04/04/2007EP1377556B1 Pyrazole derivatives for treating hiv
04/04/2007EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
04/04/2007EP1219609B1 Aromatic nitrogenous six-membered ring compounds
04/04/2007EP1092435B1 Remedies for diabetes
04/04/2007CN1942472A Reverse-turn mimetics and method relating thereto
04/04/2007CN1942470A Akt活性抑制剂 Akt activity inhibitor
04/04/2007CN1942190A Pyrrole derivatives as gonadotropin releasing hormone (GnRH) antagonists
04/04/2007CN1939919A Low-toxic and broad-spectrum phthalocyanine bactericide, its production and use
04/04/2007CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
04/04/2007CN1308328C Novel process for the preparation of pyrazolopyrimidinones
04/04/2007CN1308327C Imidazopyridine derivatives
04/04/2007CN1308313C Fused azepine drivatives and their use as antidiuretic agents
04/04/2007CN1308310C Nitrogenous aromatic ring compounds
04/04/2007CN1308305C Method for synthesizing imide base substituted endo compound
04/03/2007US7199248 Process
04/03/2007US7199121 Protein tyrosine phosphatase inhibitor
04/03/2007CA2296586C New 2,3-benzodiazepine derivatives
04/03/2007CA2236269C Selective .beta.3 adrenergic agonists
03/2007
03/29/2007WO2007035841A1 Analogs of dehydrophenylahistins and their therapeutic use
03/29/2007WO2007035542A1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
03/29/2007WO2007034952A1 Luminescent vargula luciferin substrate and process for producing the same
03/29/2007WO2007034278A2 Fused imidazole derivatives as c3a receptor antagonists
03/29/2007WO2006130657A3 Stereoselective reduction process for the preparation of pyrrolotriazine compounds
03/29/2007WO2006125101A3 Raf inhibitor compounds and methods of use thereof
03/29/2007WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists
03/29/2007WO2006094210A3 Tetrahydroquinoxalinone sirtuin modulators
03/29/2007WO2006078676A3 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/29/2007WO2006067419A3 Myrtaceous honey and the use thereof as immunomodulator
03/29/2007WO2006024841A3 Benzamide compounds
03/29/2007US20070073095 porphyrins or phthalocyanines; for chemical warfare, volatile organic compounds
03/29/2007US20070073059 Method of producing azomethine dye compound
03/29/2007US20070073053 Naphthalocyanine dye and method for producing the same
03/29/2007US20070072888 Indol-3-yl-carbonyl-azaspiro derivatives
03/29/2007US20070072882 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/29/2007US20070072881 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/29/2007US20070072880 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/29/2007US20070072879 Novel compounds as metabotropic glutamate receptor antagonists
03/29/2007US20070072867 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-YL)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5amine
03/29/2007US20070072865 Bicyclic piperazine compound and use thereof
03/29/2007US20070072864 fused tricyclic compounds useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists
03/29/2007US20070072863 thieno [2,3-b: 5,4-c'] dipyridine derivatives, used as as selective metabotropic glutamate receptor 1 (mGluR1) antagonists, for the treatment of pain, headaches, anxiety, incontinence and neurodegenerative diseases such as Alzheimer's disease
03/29/2007US20070072851 Pyrazolopyridine and pyrazolopyrimidine compounds
03/29/2007US20070072849 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
03/29/2007US20070072846 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
03/29/2007US20070072844 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/29/2007US20070072841 Therapeutic compounds
03/29/2007US20070072838 High-purity texaphyrin metal complexes
03/29/2007US20070072825 Erectile dysfunction, urinary incontinence, lung disease, hyperoxia, neurodegenerative disease, liver disease, myocardial damage during cardioplegia, an inflammatory condition, a reperfusion injury, an ischemic condition, a cardiovascular disease, diabetes, cancer
03/29/2007US20070072812 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
03/29/2007US20070072792 Macrocyclic lactams and pharmaceutical use thereof
03/29/2007DE102005017326A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories
03/29/2007DE10116303B4 Vefahren zur Herstellung N-überbrückter Heterobicyclen Vefahren for preparing N-bridged heterobicycles
03/29/2007CA2622741A1 2-heteroaryl-pyrazolo-[4, 3-e]-1, 2, 4-triazolo-[1,5-c]-pyrimidine as adenosine a2a receptor antagonists
03/29/2007CA2619068A1 Imidazole compounds for the treatment of neurological disorders
03/28/2007EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists
03/28/2007EP1765827A2 A method for preparing pyrrolotriazine compounds
03/28/2007EP1765826A2 Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles
03/28/2007EP1765825A1 Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases
03/28/2007EP1765824A1 Substituted 6-phenyl-7-amino-triazolopyrimidines, method for the production thereof, their use for controlling pathogenic fungi, and agents containing these compounds